ABMT (Advanced BioMedical Technologies) ROE % Adjusted to Book Value: 0.00% (As of Jul. 2021)


What is Advanced BioMedical Technologies ROE % Adjusted to Book Value?

Advanced BioMedical Technologies ABMT ROE % Adjusted to Book Value is 0.00% as of Jul. 2021.

Advanced BioMedical Technologies's ROE % for the quarter that ended in Jul. 2021 was 0.00%. Advanced BioMedical Technologies's PB Ratio for the quarter that ended in Jul. 2021 was N/A. Advanced BioMedical Technologies's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2021 was N/A.

Advanced BioMedical Technologies ROE % Adjusted to Book Value Related Terms

Advanced BioMedical Technologies ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies ROE % Adjusted to Book Value Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ABMT vs VYCO, ADMT, THMO: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's ROE % Adjusted to Book Value falls into.


Advanced BioMedical Technologies ROE % Adjusted to Book Value Calculation

Advanced BioMedical Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Advanced BioMedical Technologies's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Advanced BioMedical Technologies (ABMT) has a ROE % Adjusted to Book Value of 0.00% as of Jul. 2021. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' ROE % Adjusted to Book Value too high?
Advanced BioMedical Technologies' current ROE % Adjusted to Book Value is 0.00%.
How does Advanced BioMedical Technologies' ROE % Adjusted to Book Value compare to VYCO and ADMT?
Advanced BioMedical Technologies' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current ROE % Adjusted to Book Value is 0.00% as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.